GAL3ST1

gene product
CST
Sulfonation, an important step in the metabolism of many drugs, xenobiotics, hormones, and neurotransmitters, is catalyzed by sulfotransferases. This gene encodes galactosylceramide sulfotransferase, which catalyzes the sulfation of membrane glycolipids including the final step in the synthesis of sulfatide, a major lipid component of the myelin sheath. This gene exhibits elevated expression in ovarian epithelial carcinoma and the encoded enzyme exhibits elevated activity in renal cell carcinoma. Mutations in this gene may be associated with reduced insulin resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
143 antibodies from 19 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
33 antibodies
Novus Biologicals
5 antibodies
Atlas Antibodies
1 antibody
Aviva Systems Biology
2 antibodies
Abnova Corporation
5 antibodies
Invitrogen Antibodies
2 antibodies
NovoPro Bioscience Inc.
1 antibody
RabMAbs
2 antibodies
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
55 antibodies
Biorbyt
7 antibodies
MyBioSource
4 antibodies
GeneTex
1 antibody
OriGene
1 antibody
Signalway Antibody LLC
1 antibody
Creative Diagnostics
4 antibodies
Creative Biolabs
3 antibodies
Sigma-Aldrich
2 antibodies
United States Biological
13 antibodies